期刊文献+

线粒体DNA 13731点突变与脊髓小脑性共济失调相关性研究 被引量:1

Mitochondrial DNA point 13731 mutation in spinocerebellar ataxia
下载PDF
导出
摘要 目的探索线粒体DNA(mtDNA)突变位点与脊髓小脑性共济失调(SCA)的关系。方法采用聚合酶链反应(PER)对基因确诊的四个SCA家系10例患者及其亲属共34例与40例健康对照的线粒体ND5基因片段进行扩增,扩增产物进行单链构象多态性分析(SSCP),对SSCP出现异常的样本进行相应mtDNA片段测序。结果在一家系的1名确诊患者及1名症状前患者检测到mtDNA13731(T〉C)点突变。结论脊髓小脑性共济失调的发生、发展可能与mtDNA突变有关。 Objective To study the possible relationship between the point mutation in mitochondrial DNA (mtDNA) and the progression spinocerebellar ataxia(SCA). Methods Polymerase chain reaction(PCR) was used to amplify the mtDNA segments of these patients and their relatives individuals,40 volunteers. The mtDNA segment lied in the above mtDNA ND5 gene. For PCR products of the mtDNA segment, single strand conformation polymorphism (SSCP) was executed to detect mutations and the abnormal segments were sequenced. Results We had found a new mtDNA mutation in segments of mtDNA point 13731 (T 〉 C) ,was identified in 1 patient and 1 presymptomatic relatives. Conclusion A new point mutation of detected mitochondrial DNA may be lated to SCA.
作者 王栋慧 王进
出处 《中国临床新医学》 2009年第7期671-674,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西自然科学基金项目(桂科目0339049)
关键词 脊髓小脑性共济失调 线粒体DNA 点突变 SpinocerebeUar ataxia Mitochondrial DNA Pointmutation
  • 相关文献

参考文献6

  • 1Laszlo Tretter,Ildiko Sipos,Vera Adam-Vizi.Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson’s Disease[J].Neurochemical Research.2004(3)
  • 2Li W,Gao F,Liang J,et al.Estimation of the optimal eleetrophorectic temperature of DNA sin~e strand conformation polymo~Msm by DNA base composition[].Electrophoresis.2003
  • 3Kawaguchi Y,Okamoto T,Taniwaki M,et al.CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1[].Nature Genetics.1994
  • 4Tang B,Liu C,Shen L,et al.Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar Ataxia From Chinese Kindreds[].Archives of Neurology.2000
  • 5Van AN,Sinke RJ,Zwarts MJ,et al.Intermediate CAG repeat lengths ( 53,54 ) for MJD/SCA3 are associated with an abnormal phenotype[].Annals of Neurology.2001
  • 6Blok MJ,Spruijt L,de Coo IF,Schoonderwoerd K,HendrickxA,Smeets HJ.Mutations in the ND5subunit of complexI of the mito-chondrial DNA are a frequent cause of oxidative phosphorylation disease[].Journal of Medical Genetics.2007

同被引文献30

  • 1Modica-Napolitano J, Singh K.Mitochondrial dysfunction in cancer[J]. Mitochondrion,2004,4(5-6):755-762.
  • 2Manoli I,Alesci S,Chrousos G. Mitochondria in G.Fink (Ed.),Encyclopedia of Stress[M].second ed.,Academic Press,San Diego,2007:754-761.
  • 3DiMauro S,Tanji K,Bonilla E,et al.Mitochondrial abnormalities in muscle and other aging cells:classi? cation, causes, and effects[J]. Muscle Nerve,2002,26(5):597-607.
  • 4Keller JN,Glazner GW. Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders,in:M.P.Mattson (Ed.),Advances in Cell Aging and Gerontology:Interorganelle Signaling in Age-Related diseases[M].2001:205-237.
  • 5Wang X,Su B,Lee H,et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease[J].J Neurosci,2009,29(28):9090-9103.
  • 6Torchilin VP.Recent approaches to intracellular delivery of drugs and DNA and organelle targeting[J]. Annu Rev Biomed Eng,2006,8:343-375.
  • 7Horobin RW,Trapp S,Weissig V. Mitochondriotropics:a review of their mode of action,and their applications for drug and DNA delivery to mammalian mitochondria[J]. J Control Release, 2007,121(3):125-136.
  • 8Smith RAJ.Murphy.Mitochondria-targeted antioxidants as therapyes[J].Discov Med, 2011,11(57):106-114.
  • 9Souza GGMD,Boddapati SV,Weissig V. Gene therapy of the other genome:the challenges of treating mitochondrial DNA defects[J]. Pharm Res,2007,24(2):228-238.
  • 10Yousif LF,Stewart KM,Horton KL,et al.Mitochondria-penetrating peptides:sequence effects and model cargo transport[J]. Chem Bio Chem, 2009,10(12):2081-2088.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部